Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10342800 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
Condition: Crohn's Disease
Interventions: Drug: Methotrexate;   Drug: Placebo

Indicates status has not been verified in more than two years